August 29, 2014

Biotechnology, Food & Drug Administration FDA News

The National Law Review includes articles impacting the biotech and cleantech fields addressing: licensing and patent issues, intellectual property due diligence, litigation and tax. Content is also included addressing: greenhouse gas (GHG) regulation; mandated emissions reduction legislation; NEPA and CEQA claims, common law nuisance litigation; acquiring and selling emission offset and emission reduction credits and acid rain allowances under the United States Clean Air Act, SCAQMD RECLAIM and other air credit programs.

Date Title Organization
29
Aug
Pharmacies Avoid False Claims Act Suit: Fox Rx Inc. v. Omnicare Inc. et al. Covington & Burling LLP
28
Aug
Hawaii G-M-O: Kauai County GMO Regs Struck Down in Federal Court Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
28
Aug
Third Circuit Holds Irreparable Harm May Not Be Presumed In Lanham Act False Advertising Cases To Establish Entitlement To Injunctive Relief Proskauer Rose LLP
27
Aug
Genus Claims Require Disclosure of “Representative Species Encompassing the Breadth of the Genus” McDermott Will & Emery
27
Aug
Selection Invention Found Unpatentable for Obviousness-Type Double Patenting Sterne, Kessler, Goldstein & Fox P.L.L.C.
27
Aug
Tennessee Employer Gets New Trial to Prove Drug Tests Were Not Medical Examinations or Disability-Related Inquiries Jackson Lewis P.C.
26
Aug
Health Care Law Update - August 25, 2014 Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
25
Aug
Northern District of Illinois Court Answers the Question: What KIND of Juice Did They Say It Was? Proskauer Rose LLP
25
Aug
FDA Notifies Congress of Framework for Long-Awaited Guidance on Laboratory Developed Tests and Issues Final Guidance on Companion Diagnostics Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
25
Aug
FDA Issues Draft Guidance on De Novo Process Barnes & Thornburg LLP
25
Aug
Medical Device Update: FDA Issues Draft Guidance on Streamlined De Novo Classification Process Morgan, Lewis & Bockius LLP
25
Aug
Prescription Drugs: Refocusing the False Claims Act Microscope on the Rest of the Transaction Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
25
Aug
Physicians Write Letter to FDA Regarding Biosimilar Naming Concerns McDermott Will & Emery
25
Aug
FDA’s Announced Framework for Regulating Laboratory Developed Tests (LDTs) Leaves Open Many Questions Covington & Burling LLP
22
Aug
Office of Inspector General (OIG) Finds Risk of Abuse in Specialty Pharmacy’s Per-Fill Fee Proposal Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
22
Aug
Pennsylvania Federal Judge Upholds Poaching Claims in Pharmaceutical Data Antitrust Case McDermott Will & Emery
21
Aug
Liquor License Lottery Drawing Application Period Opens for Florida Lowndes, Drosdick, Doster, Kantor & Reed, P.A.
21
Aug
Minnesota Drug Testing Law Does Not Apply to Employees Working Outside Minnesota Jackson Lewis P.C.
21
Aug
FDA Says “Fuhgeddaboudit” To Its Own Proposed Pre-Decisional IDE Process Barnes & Thornburg LLP
21
Aug
Second Circuit Clarifies the Use of Legal Presumptions of Consumer Confusion and Injury in Certain Lanham Act Cases Sheppard, Mullin, Richter & Hampton LLP

Advertisement

LATEST LEGAL NEWS & ANALYSIS

Bilzin Sumberg Baena Price & Axelrod LLP
Womble Carlyle Sandridge & Rice, PLLC
Giordano, Halleran & Ciesla, P.C.

TRENDING LEGAL ANALYSIS